Rubicon Minerals Transmettre P/E
Quel est le Transmettre P/E de Rubicon Minerals?
Le Transmettre P/E de Rubicon Minerals Corp. est -5.58
Quelle est la définition de Transmettre P/E?
Le ratio prix à terme/bénéfice est le rapport entre le prix des actions d'une société et son bénéfice par action estimé pour les douze prochains mois.
The forward price to earnings ratio is similar to trailing price to earnings ratio but instead of net income uses estimated net earnings over next 12 months. Estimates are typically derived as the mean of those published by a select group of analysts with selection criteria varying. The forward price-to-earnings ratio is a powerful, but limited tool. It allows a quick snapshot of the company’s finances without getting down in the details of an accounting report.
Transmettre P/E des entreprises dans Materials secteur sur TSX par rapport à Rubicon Minerals
Que fait Rubicon Minerals?
Rubicon Minerals Corporation engages in the exploration and development of gold properties in Canada and the United States. The company holds a 100% interest in Phoenix Gold project located in the Red Lake gold district in northwestern Ontario, Canada. It also holds interests in approximately 285 square kilometers of exploration ground in the Red Lake gold district; and approximately 900 square kilometers of mineral property interests in the Long Canyon gold district in the Nevada-Utah border. The company was founded in 1996 and is headquartered in Toronto, Canada.
Entreprises avec transmettre p/e similaire à Rubicon Minerals
- Icad Inc a Transmettre P/E de -5.74
- Greenpro Capital a Transmettre P/E de -5.64
- Greenpro Capital a Transmettre P/E de -5.64
- Parkson Retail a Transmettre P/E de -5.64
- Outlook Therapeutics Inc a Transmettre P/E de -5.59
- Allot Ltd a Transmettre P/E de -5.58
- Rubicon Minerals a Transmettre P/E de -5.58
- Recro Pharma Inc a Transmettre P/E de -5.58
- Atossa Therapeutics Inc a Transmettre P/E de -5.56
- Nephros Inc a Transmettre P/E de -5.56
- Avinger Inc a Transmettre P/E de -5.55
- Intercept Pharmaceuticals Inc a Transmettre P/E de -5.54
- Opko Health Inc a Transmettre P/E de -5.52